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  Unintended pregnancies are a long-standing public health issue nationally, with 
percentages hovering around 50% for at least the last five years. Vermont is doing 
slightly better than the national average, but is faced with it’s own challenges due to it’s 
rural nature. Agencies and organizations, such as the World Health Organization, March 
of Dimes and the Vermont Department of Health have made decreasing unintended 
pregnancies one of their priorities to improve maternal and fetal health outcomes, as well 
as social and economic opportunities for families. Current evidence-based guidelines call 
for long- acting reversible contraceptives (LARCs), including intrauterine devices (IUDs) 
and implants, as the first-line recommendation by healthcare providers for decreasing 
unintended pregnancies.  
 This study, in collaboration with several Vermont state organizations and 
agencies, engaged healthcare professionals throughout the state with an electronically 
disseminated survey aimed at assessing their knowledge of LARCs. The aim of this study 
was to ascertain whether healthcare professionals caring for women of reproductive age, 
are using current evidence-based practice guidelines to counsel women in their 
contraceptive choices.   
 Survey results revealed that the majority of the respondents consider themselves 
to be knowledgeable about and had received a high level of training in IUD  counseling 
and/or insertion. Areas of uncertainty were primarily about side effects and the insertion 
and removal processes of the implant, as well as a few categories of medical eligibility. 
This was especially apparent when results were stratified by urban and rural regions of 
Vermont. 
 Although there seems to be a high level of provider confidence in knowledge 
about LARCs and reported counseling of LARCs as first-line, there is a discrepancy 
between what providers think they know and current evidence based contraception 
guidelines. Many factors exist that could explain this discrepancy, including but not 
limited to lack of training, provider bias, and system barriers. This study aims to 
illuminate gaps in provider knowledge to improve uptake of LARCs and over time make 
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 In 2010, 46% of all pregnancies (4,000) in Vermont were unintended, a figure 
placing the state just below the national average, but still startlingly high. At the same 
time, the teen pregnancy rate was 32 per 1,000 women aged 15-19 compared to a national 
teen pregnancy rate of 57 per 1,000 (Guttmacher, 2015). Although it appears that 
Vermont is having some success with its prevention of overall unintended pregnancies as 
compared to the rest of the United States, there are ways in which this public health issue 
could be vastly improved upon. A safe, economical, and proven method for reducing 
unintended pregnancies for all aged women are long-acting reversible contraceptives 
(LARCs), including intrauterine devices (IUDs) and the single-rod contraceptive implant. 
These methods are highly effective, yet under-utilized in the United States, begging the 
question, “how is Vermont doing with its use of LARCs?” The increased use of LARCs 
by Vermont providers among women of reproductive age could influence these 
unintended pregnancy statistics positively, improving social, economic and health 
outcomes for women, children and families across the state. Yet, we do not understand 
the level of knowledge Vermont health care providers have about LARC, nor what 
knowledge gaps exist. Hence, the purpose of this study was to understand the knowledge 
and practices of Vermont health care providers’ related to long-acting reversible 
contraception.. It is hoped that the results of this study will ultimately contribute to 
increased provider counseling and implementation, improved uptake of LARCs as 




Background and Significance: 
Long-Acting Reversible Contraceptives 
 LARCs have two categorizations:  IUD and the single rod, progestin subdermal 
implant (Nexplanon®). IUD models are either levonorgestrel hormonal (Mirena®, 
Skyla® and LilettaTM) or copper T380A (ParaGard®), 
 The levonorgestrel intrauterine system (LNG-IUS) is a T-shaped polyethylene 
frame containing 52 mg of levonorgestrel that is released at a rate of 20 micrograms per 
day for five years. After five years, the daily dose decreases by 50% (McNicholas & 
Peipert, 2012). The LNG-IUS prevents pregnancy and fertilization by thickening cervical 
mucus, inhibiting sperm motility, and thinning the endometrial lining. In some women, 
ovulation may be suppressed (McNicholas & Peipert, 2012). Other non-contraceptive 
benefits of the LNG-IUS include decreased monthly blood loss and reduction of 
dysmenorrhea.  
 The CuT380A IUD is a T-shaped, non-hormonal, polyethylene frame wrapped in 
copper wire. Pregnancy prevention is achieved through inhibition of fertilization. The 
ionic charge of the copper also has a spermicidal effect, (McNicholas & Peipert, 2012). 
Another benefit of the CuT380A IUD is its use as emergency contraception within five 
days following unprotected intercourse; it should be pointed out that this is the only time 
the IUD is believed to work by inhibiting implantation rather than fertilization. Due to the 
fact that it is non-hormonal, there is a consistent rapid return to fertility among users. 
(McNicholas & Peipert, 2012). Because of the potential to use this method for up to 12 
years, this is also the most cost-effective contraceptive option, although it may be chosen 
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less frequently due to reported negative side effects, including menorrhagia and/or 
dysmenorrhea.  
 In addition to their excellent contraceptive profiles, the levonorgestrel-releasing 
IUD has been shown to aid in the prevention of endometrial and cervical cancer 
(McNicholas & Peipert, 2012). The mechanism of action is that progestin effects on the 
endometrium serve to protect against and cause regression of endometrial hyperplasia 
(Yoost, 2014).   
 There is only one contraceptive implant available in the United States: the 
etonogestrel-releasing subdermal (ENG) implant. ENG is a single rod, progestin-only 
implant that measures 4 cm in length and 2 mm in diameter and contains barium for 
radiographic identification. The ENG is inserted at the inner side of either upper arm 
about 8-10 cm above the medial epicondyle of the humerus in the sulcus between the 
bicep and triceps muscles (Merck Sharp & Dohme, 2011). ENG is currently approved for 
three years, and like the IUD, provides excellent contraceptive effectiveness. It works 
primarily through ovulation inhibition as well as thickening of cervical mucus. This 
method has been shown to appeal to younger age groups due its ability to improve acne 
and relieve dysmenorrhea, as well its non-user dependence for efficacy. Additionally, a 








Unintended Pregnancies  
 Population trends for the last 20 years consistently indicate that 51% of 
pregnancies are unintended across the United States (Finer & Zolna, 2014). According to 
the Centers for Disease Control there are higher proportions of unplanned pregnancies 
(UPs) among adolescent and young women, women who are racial/ethnic minorities, and 
women with lower levels of education and income (2014). Approximately half of UPs are 
among women who were not using contraception at the time they became pregnant and 
the other half are among women who became pregnant despite reported use of 
contraception indicating imperfect use of these methods (CDC, 2013). There are many 
consequences linked to these UPs, including delayed prenatal care, worse maternal and 
fetal outcomes, premature birth and negative physical and mental health effects for 
children, only to name a few (The Guttmacher Institute, 2015). Other negative outcomes 
include higher costs to the overall healthcare system and economy, with annual direct 
costs at $4.5 billion yearly (Committee on Adolescent Health Care Long-Acting 
Reversible Contraception Working Group, 2012). 
 Additional burdens affecting young women, especially adolescents experiencing 
unplanned pregnancies include depressed educational, social and economic opportunities. 
Only about half (51%) of teen mothers get a high school diploma by age 22 compared to 
89 percent of women who didn’t have a teen birth. If a teen has a child before the age of 
18, they are even less likely to graduate from high school at 38% obtaining a high school 
diploma and about 19% getting their General Education Development. Additionally, less 
than 2% attain a college degree by 30 years old, (Ng & Kaye, 2012). While there are 
confounding factors to consider, numerous studies reveal that teen childbearing is 
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significantly associated with discontinuation or serious delay of education and decreased 
future earnings and employment opportunities. According to the National Campaign to 
Prevent Teen and Unplanned Pregnancy, roughly 48% of all mothers age 15 to 19 were 
living below the poverty line from 2009-2010. Teen mothers living with family had 
slightly better statistics, with 34% living below the poverty line. Impact of teen 
childbearing is also stratified by race, with higher numbers of Hispanic, non-white 
women living at the poverty level. Research has also shown that children of adolescent 
mothers have higher rates of abuse and neglect, are more likely to become teen mothers 
themselves and are more likely to be incarcerated, (The National Campaign to Prevent 
Teen Pregnancy, 2007). 
 
Contraception Recommendations 
 A topic that has gained traction in US healthcare in the last decade is the use of 
more efficient contraception, namely LARCs, to reduce overall numbers of UPs. LARC 
methods have many advantages including excellent safety profile, non-user dependence, 
and ease of placement after minimal provider training (Committee on Adolescent Health 
Care Long-Acting Reversible Contraception Working Group, 2104). They have also been 
shown to have higher continuation rates after one year (>80%) than other reversible 
methods (49% to 57%) and are more cost-effective over time than other forms of 
contraception (Hathaway et al., 2014).  
 Recommendations for increased use of LARCs was highlighted in 2007, when the 
American Congress of Obstetricians and Gynecologists (ACOG) Committee Opinion 
stated that IUDs should be considered as first-line choices for both nulliparous and 
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parous adolescents (American College of Obstetricians and Gynecologists, 2007). To 
address barriers to placement, ACOG published another set of recommendations in 2009, 
encouraging LARCs for all appropriate candidates of reproductive age and urging 
providers to avoid delays to placement, specifically to adopt same-day insertion 
protocols, including placement immediately post-abortion, or vaginal or C-section birth 
(ACOG, 2009). These recommendations were reaffirmed in 2014 by both the ACOG and 
American Academy of Pediatrics, which both urged providers to recommend LARC’s as 
first line contraception. Additionally, the Centers for Disease Control and Prevention 
emphasized the importance of increasing access to LARC methods to reach the Healthy 
People 2020 objective of reducing unintended pregnancy rates from 49% to 44% (United 
States Department of Health and Human Services, 2012). 
 Even though these recommendations have been in place for almost 10 years, the 
current use of IUDs and implants amongst US women is 11.6% (Daniels et al., 2015), 
which is low when compared against most European countries, including France 23%, 
Finland 26% and Norway at 27% where healthcare systems focus on preventive and 
primary care (Mosher & Jones, 2010). Current trends suggest that the majority of 
sexually active women in the United States are using oral contraceptives (25.9%), 
sterilization (female 25.1%), and condoms (male) at 15.3%. Other short acting reversible 
contraceptives (SARCs) include the vaginal ring or transdermal patch (2.6%), and 
hormonal injections (4.5%). Withdrawal and other methods are reported at 6.8% (Daniels 
et al., 2015). The failure rate of oral contraceptives with typical use (as opposed to perfect 
use) hovers around 10%, where failure rates of male condom use are closer to 20%, 
almost equal to the withdrawal method (CDC, 2013). LARCs failure rate is almost 
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equivalent to sterilization at 0.2%, yet is not consistently recommended as first line by 
most providers (Harper et al., 2013).  
Barriers to LARC Use 
 Providers may be reluctant to promote LARCs due to their historical controversy, 
initial marketing to limited patient populations and changing recommendations over the 
years by both pharmaceutical companies and national guideline organizations. A 
significant historical factor was the creation of the Dalkon Shield, an IUD that had some 
serious design flaws that increased the risk of pelvic inflammatory disease, infertility and 
septic abortions due to its higher pregnancy prevention failure rate (Harper et al., 2008). 
At that time, in the 1970s, IUD use was on the rise, as women were attracted to the 
“forgettable” nature of the method and it’s high efficacy in pregnancy prevention. 
Following the negative publicity and health scares tied to the unique flaws of the Dalkon 
Shield, all IUDs lost public and provider favor.  
  Often cited reasons for limited uptake of LARCs are patients’ fear, and lack of 
information or knowledge. These could be due to limited counseling on LARC methods, 
persistent historical bias regarding IUD safety, perceived negative experiences relayed 
from woman to women regarding discomfort of the procedures or side effects, and the 
influence of pharmaceutical marketing to name a few.  
 Outdated or insufficient provider knowledge is certainly a barrier to increased 
uptake of LARCs. For instance, Mirena® IUD initially was only marketed to parous 
women and placement was considered optimal during menses. Some providers have held 
onto these practices, even though they have been proven unnecessary. Additionally, many 
conditions have previously precluded women from being offered LARCs. For instance, 
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IUD use was formerly contraindicated for women with previous pelvic inflammatory 
disease (PID) or chlamydia/gonorrheal infections, history of ectopic pregnancy or 
hypertension, smokers, HIV-positive women and diabetic and obese women. Other 
outdated knowledge concerning side effects of IUD’s that precluded placement include 
belief that they increase risks of PID, tubal infertility and decreased bone mineral density 
(Yoost, 2014). 
 Insufficient or lack of training in IUD and implant counseling and insertion is 
another barrier to provider use of LARCs. Multiple opportunities for training in these 
areas are available to healthcare providers, including training embedded into the medical 
or nursing education program, at the work site, through CME/CEUs, or as a part of a 
medical or nursing residency or fellowship (Harper et al., 2012). A practitioner must have 
the desire to offer these services, support from their practice setting, as well as the 
appropriate patient population. Despite receiving training, skills may remain unused or be 
forgotten if not implemented on a regular basis.  
 Although the Affordable Care Act has significantly reduced the cost barrier for 
some women, it is still cited as a major obstacle to obtaining a LARC. Upfront costs of 
IUDs and implant devices without insurance, not including insertion and removal fees are 
between 500 dollars and 700 dollars. This is prohibitive for many women who may not 
have comprehensive health insurance coverage or insurance that still requires cost-







Current Status of LARC 
 Four IUDs and a few iterations of implantable hormonal rods have since come on 
the market with excellent safety and pregnancy prevention profiles. Currently, the 
Centers for Disease Control and Prevention Medical Eligibility Criteria gives IUDs and 
implants a classification of 1 or 2, meaning that there is either (1) no restriction for the 
use of the contraceptive method or (2) that the advantages of using the method generally 
outweigh the theoretical or proven risks (CDC, 2010). Additionally, The CDCs most 
recent report on US Selected Practice Recommendations for Contraceptive Use affirms 
that LARC can be used in almost all women of childbearing age as long as providers are 
reasonably certain that these patients are not already pregnant (Hathaway et al, 2014). 
Despite this updated safety profile and guideline, providers continue to exclude many 
patients from being offered LARCs (Harper, 2015).  There are a few true 
contraindications to the use of IUDs. Those contraindications include: current 
mucopurulent discharge, acute cervicitis, current pregnancy, copper allergy (for copper 
IUD), congenital uterine abnormalities or cervical or uterine malignancies. The 
levonorgestrel intrauterine system (LNG-IUS) and implant also should not be initiated or 
continued when severe cirrhosis or breast cancer are present (Hathaway et al., 2014).  
 Research has repeatedly proven the incredibly low failure rate of IUDs and 
implants, yet the small percentage of users would suggest that contraception providers are 
not recommending LARCs based on misinformation regarding best practice guidelines, 
outdated knowledge, or are faced with institutional, policy or other barriers and 
challenges (Biggs et al., 2014).  
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 Potential barriers to use are created by provider personal bias, lack of formalized 
training, perceived lack of patient interest, insurance company reimbursement models and 
outdated individual clinic policies regarding availability of the contraceptive products or 
protocols for placement. Some insurance companies require prior approval for payment 
of the IUD or implant procedure, while some clinics/practices necessitate a two-part visit, 
including counseling sessions and screening tests prior to LARC insertion. These barriers 
result in many women being lost to follow-up and placed at risk of an unintended 
pregnancy (Bergin et al., 2012).      
 
Project Significance 
 Unintended pregnancies are considered to be a public health issue in Vermont. 
46% of all pregnancies are unintended in Vermont, with higher numbers for younger 
women, including 81% for teenagers and 67% for women ages 20-24 (VT Department of 
Health, 2015). This data highlights that there is clearly room for improvement in terms of 
patient contraception counseling and education. To date, there has not been a study 
specifically investigating the LARC knowledge and practices of Vermont healthcare 
providers. This study will shed light on factors that may be contributing to low LARC 
uptake by women. Some variables that will be considered are perceived knowledge of 
current guidelines and best practice around contraception counseling, and what health or 
demographic factors are being taken into consideration with the recommendation of 
certain contraception methods. This survey-based research will guide organizations 
around the state in their efforts to update providers’ knowledge and practices in the 
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counseling and provision of LARCs. The long-term measurable goal, beyond the scope of 
this research, will be a decrease of unintended pregnancies in Vermont. 
 
Research Objectives 
 To meet the purpose of understanding the educational and training needs of 
Vermont health care providers related to LARCs, the objectives of this study are to:  
1. Describe health care providers’ perceived LARC knowledge base 



















Chapter II: Literature Review 
Theoretical Framework 
 Nurse Practitioners (NPs) have an important role to play in the increased 
provision of LARC’s. Aside from being trained in counseling, insertion procedures and 
referral processes, they also bring a unique perspective grounded in nursing theory to 
patient interactions. Nola Pender’s Health Promotion Model is especially applicable to 
patient contraception counseling and guides the foundational perspective for this research 
process. Pender’s theory takes into account the complex factors that contribute to a 
person’s health-related decisions. The Health Promotion model encourages providers to 
consider a patient’s family and community, environment, and their own definition of 
health to guide the nursing process (Butts & Rich, 2011). Other applicable assumptions 
made by the model include:  people seek to actively regulate their own behavior, people 
value growth in directions viewed as positive and attempt to achieve a personally 
acceptable balance between change and stability and that health professionals constitute a 
part of a patients interpersonal environment and can therefore influence decision making 
and behavior change (Pender, 2011). In terms of making decisions about contraception, a 
patient is likely to be influenced by friends, family and healthcare providers’ opinions 
and experiences, their economic resources and their self-perception of health.  Patients 
are certainly biased by the experiences of people who are close to them, and may have a 
pre-conceived notion about financial and health costs of particular types of 
contraceptives. For instance, patients may choose the copper IUD due to its “natural”, 
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non-hormonal method, but may be unaware of the potential side effects of menorrhagia 
or dysmenorrhea. If these are symptoms a patient is already struggling with, the Nurse 
Practitioner can be a source of information, to guide a patient towards behaviors and 
decisions that best promote their health, while holding the patient’s value system in high 
regard. One area where Pender’s Health Promotion model can be most helpful is in the 
prevention of delay of placement of IUD’s and implants, especially post-abortion or post-
partum. If a patient has a high number of unintended pregnancies ending in abortion, 
birth, adoption, miscarriage, etc., they may be particularly good candidates for immediate 
LARC implementation. NPs, using the health promotion model, can identify these 
patients as benefactors for behavior change and promote a patient’s self-efficacy in 
making a decision to not delay LARC placement. Nurse practitioners are also key players 
in counseling patients, guiding them to identify their intention (no more unintended 
pregnancies), make goals and plans that they perceive to be reasonable and attainable and 
commit to a plan of action. This could all reasonably occur over the course of one 
appointment, which would potentially end with LARC placement.  Due to the nature of 
Pender’s Health Promotion Model, patients have the opportunity to direct their own care 
under the guidance, supervision, and encouragement of an NP. Ideally, this provides the 
patient with a sense of empowerment and self-efficacy to choose contraception that best 
suits their situational or family planning needs based on clear, fact-based, evidence-
guided counseling.  
 Pender’s Health Promotion Model is an appropriate foundation for this study 
because it reflects the importance of shared decision-making between the provider and 
patient and patient-centered care. The model emphasizes provider influence in a patients 
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decision making process, which is pertinent considering the key role that counseling 
plays in a woman’s contraceptive choice. When providers practice based on current 
evidence based guidelines, with a tiered counseling approach, they afford women the 




 This research represents three nurse practitioner competencies, as stated by the 
National Organization of Nurse Practitioner Faculties (NONPF, 2013); leadership, 
quality, and ethics. This study was undertaken as a part of a larger study with the 
Vermont Child Health Improvement Program (VCHIP). As an example of leadership, 
this author was able to connect with the VCHIP project team, establish a relationship and 
collaborate to create and implement the provider survey. Additionally, the larger scope of 
the project aims to “influence health outcomes of a population focus” (NONPF, 2012, p. 
2), namely, Vermont women of reproductive age.  
 This study also embodies the core competency of quality, as its aims are to 
investigate whether providers are using the best available evidence to provide quality 
clinical care. Furthermore, it explores variations in knowledge between providers, to 
determine what interventions can be implemented to ensure excellent standardized care. 
 Finally, ethics is an underlying variable of interest. Providers are bound by ethical 
principles in their practice, including non-maleficence, social justice and encouraging 
patient autonomy in decision-making. Family planning and reproductive rights involve 
much bigger issues than just choosing a form of birth control. These issues include but 
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are not limited to, education and career planning, financial stability and dynamic 
relationships. Providers are ethically obligated to be knowledgeable about and non-biased 
in their delivery of contraception counseling to best serve the reproductive priorities of 
their patients.  
 
Review of Research 
 The following literature review highlights the significance of increasing LARC 
use among women of reproductive age. First, ways in which providers are enhancing or 
limiting access to LARCs. Second, demographics of women who would most benefit 
from access to LARCs and finally, barriers to effective implementation of these effective 
contraceptive methods. 
 Of the groups significantly affected, adolescents are at an increased risk of 
unintended pregnancy. This is due to inconsistent or lack of contraception use, pediatric 
provider discomfort discussing sexual and contraception practices with teens, and 
predominant use of user-dependent contraception (Minnis, et al., 2014). Other at-risk 
groups include women living at or below poverty level, those with substance use issues, 
women who have already had multiple unintended pregnancies, those not under the care 
of a primary care provider and women without insurance (ACOG, 2015).  
 
Provider Knowledge and Current Practice 
 Healthcare providers are gatekeepers of contraceptive services, and their level of 
training and willingness to provide LARC methods are prerequisites to increased use. 
There have been a number of studies nationwide to assess multiple provider types for 
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knowledge, attitudes, training, current practice and barriers to providing LARC methods 
to their patients (Harper 2013, 2015; Philliber . These studies have all been in an effort to 
expose reasons for under-utilization and low patient uptake of LARCs.  
 Multiple studies analyze the type and amount of training providers received in 
LARC procedures and counseling. For example, Merck Pharmaceuticals provides a 
standardized training for the insertion of the Nexplanon implant. Likewise, IUD insertion 
training may be formalized in a classroom didactic and clinical setting, as a part of a 
conference or during residency/fellowship (Lunde, 2014).  
 A 2013 survey of 1,221 Fellows of the American college of Obstetricians and 
Gynecologists found that 92% of respondents reported residency training on IUDs, 
50.8% reported residency training on implants and 78.5% reported both didactic and 
clinical IUD training. Additionally, the survey indicates that implant insertion is most 
strongly associated with recent continuing education. Finally, only 31.7% of respondents 
cited the greatest barrier to implant insertion as a lack of insertion training (Luchowski et 
al., 2014).  
 A 2009 survey of 586 primary care nurse practitioners and women’s health nurse 
practitioners found that 66% of WHNPs were trained in IUD insertion, compared with 
12% of primary care NPs. Training and skills in the contraceptive implant were also low, 
with 26% of WHNPs reporting competency in insertions and only 6% of primary care 
NPs. Overall, half of NPs desired further training in LARC methods with no significant 
difference between specialties (Harper, 2013).  
 Years that multiple healthcare provider types have been in practice has also been 
investigated, in particular looking at LARC practices and attitudes of those who had 
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received training in IUD and implant insertion. Ninety-five providers from Iowa and 
Colorado who were eligible to insert IUDs and implants were included in a survey-based 
study that investigated IUD and implant insertion training, attitudes relative to LARC 
insertion, and barriers to its use and their views on eligible candidates for LARCs 
(Philliber et al., 2014). This study found that the most experienced practitioners were the 
least likely to have received training in LARC insertion, but that only 88% of newly 
trained practitioners had received training in IUD insertion, with only 74% trained in 
implant insertion. An interesting finding is that the most novice practitioners (1-9 years) 
reported the most comfort with LARC insertion, with those at mid-career (10-19 years) 
reporting the least comfort. Those with the most experience (>20 years) reported 
moderate comfort with the procedures. Most of the clinicians agreed that all LARC 
methods were safe for women with diabetes, smokers, history of hypertension, young 
women, and unmarried women. The most novice clinicians approved more often of 
hormonal and copper IUDs for women with a history of STIs and ectopic pregnancies 
than clinicians with the most years of experience. Although clinicians with the most 
experience overall felt comfortable with IUD procedures, they were the most 
conservative with their recommendation and implementation of LARCs. A somewhat 
counterintuitive finding of this study was that clinicians with the most years of 
experience were more liberal with their approval of implants for patients, than those with 
the most recent licenses (Philliber et al., 2014). This finding contradicts the idea that 
providers with the most years in practice would be the least comfortable with newer 
contraceptive methods, such as the implant (Philliber et al., 2014). 
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 Harper et al. also focused on provider training and practices (Harper et al., 2008), 
and inferred years of experience from reported years of licensure. Both Harper et al., 
2008 and Philliber et al., 2014, found that clinicians with a greater number of years in 
practice were less likely to be trained for LARC insertion. Subjective knowledge 
concerning medical eligibility for LARCs was variable and inconsistent amongst 
respondents (Philliber et al., 2014). 
 The above studies and others have investigated practice patterns in regards to 
patient populations considered as appropriate candidates for LARCs. Providers held the 
most restrictive practices around IUD placements and were often inconsistent with CDC 
guidelines (Harper, 2013). The 2014 Ob/gyn study by Luchowski et al. found that 51 of 
their respondents had not inserted IUDs in the past year, most frequently due to the belief 
that they act as abortifacients (23.3%) and/or because of inadequate reimbursement 
(21.6%) (Luchowski et al, 2014). Respondents from Harper et al.’s 2013 NP survey, 
especially primary care NPs, often did not view adolescent and nulliparous women as 
IUD candidates, at 29% and 45% respectively, and reported even lower candidacy for 
those with a history of ectopic pregnancy (17%), STI in the last two years (29%) and PID 
history (11%). WHNPs were twice as likely to recommend to all of these populations of 
women, but still not in line with the evidence-based CDC US Medical Eligibility Criteria 
for Contraceptive Use (Harper, 2013). Of note, results showed that women with common 
conditions seen in the primary care setting, including history of hypertension, obesity and 
diabetes were viewed as ineligible for IUD use, but were frequently prescribed estrogen-
containing methods that could put these women at an increased risk for cardiovascular 
complications (Harper, 2013).  
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 Several studies have also investigated contraceptive counseling practices amongst 
reproductive healthcare providers, including Harper’s 2013 Nurse Practitioner study 
mentioned above. The NP study found that over 75% of NPs reported having enough 
time to counsel their patients on contraceptive options, and 89% reported that their 
patients would be receptive to learning about IUDs. Even though 73% of NPs thought 
that IUDs were under-used by their patient population, only 30% of primary care NPs 
and 72% of women’s health NPs included IUDs in their contraceptive discussions 
(Harper et al., 2013).  
 
Improving uptake 
 Improved clinical counseling on LARCs as the best contraceptive option may 
improve uptake of these methods, as was shown in Harper et al.’s RCT study of family 
planning clinics across the United States where trainings were held on counseling and 
implementation (Harper et al. 2015). Priority training interventions included increasing 
providers’ knowledge of eligibility, indications for different methods, insertion skills, and 
introducing the WHO tiers-of-effectiveness evidence-based approach to contraceptive 
counseling (Harper et al. 2015). Results of LARC uptake in clinics where trainings were 
held were compared against clinics providing standard care. This revealed greater uptake 
of LARCs amongst the intervention group of providers than the control clinics, where 
oral contraceptives were recommended most frequently. This study demonstrates the 
power of a standardized, easy to replicate training to update and improve provider 
practice (Harper et al., 2015). A key factor in this research was that LARCs were offered 
at regular cost, offering a closer representation of real world practice.  
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 A significant barrier to LARC use is the upfront cost of the methods. When the 
Kaiser Foundation Health Plan in California provided full coverage without copays for 
LARCs, use of these methods increased substantially over a 5-year period (Weisman et 
al., 2014). Additionally, the well-known CHOICE study offered thousands of women 
free, same-day services and followed up for 3 years to document reproductive health and 
other outcomes. Given availability of free contraception, 70%-75% of women chose 
LARCs with a high rate if continuation (Stanback et al., 2015).  
  Improved patient knowledge depends on evidence-based, bias free, tiered 
counseling from a well-informed reproductive healthcare provider, ideally utilizing the 
World Health Organization’s tiered-effectiveness chart (WHO, 2015).  This type of 
counseling affords patients the opportunity to make a decision that supports their personal 
reproductive plan without coercion or confusion. Women believe that effectiveness is 
usually the most important factor when choosing a contraceptive method, but often lack 
accurate knowledge to make this decision (Stanback et al., 2015). Due to variables, 
including side effects, convenience, comfort-level using hormones or devices and, in 
particular, partner influences (Weisman, et al., 2014), women may not choose LARCs, 




Figure 1.1: Model of Tiered Contraceptive Effectiveness 
(WHO, 2015)  
 Increased uptake of LARCs is dependent on whether providers’ offer LARCs as 
first-line contraception options. Providers must either be offered LARC training through 
their educational track or practice setting, or independently pursue it through 
conferences/CMEs. Reproductive health care providers must do their due diligence to 
remain up to date on guidelines that are frequently in flux, to assure optimum quality care 
for patients. Unintended pregnancies stand as a public health issue, and therefore garner 
the attention of government agencies. To assist providers with the challenging task of 
staying current, the Office of Population Affairs (US Department of Health and Human 
Services) and the Center for Disease Control released evidence-based national Quality 
Family Planning Guidelines in 2014 to establish best practice for family planning 
services (Hathaway et al., 2014). An additional challenge within the changing healthcare 
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arena is the push for greater access and services offered through primary care. These 
services include LARC counseling and implementation. As Hathaway et al. point out, 
“successfully integrating LARC services into primary care can be challenging given time 
constraints and competing priorities” (p.720). Important steps, in addition to in-depth 
training, are to foster cooperation between all stakeholders within practices to support 
comprehensive contraceptive care (Hathaway et al., 2014). 
 
Adolescents at Risk 
 As cited from Henshaw and Carlin (2010), yearly approximately 750,000 
adolescents become pregnant, with 80% of these pregnancies unintended. Within this 
population, condoms are the most frequently used form of contraception (52%), with 
combined oral contraceptives and other hormonal methods being used at 31% and 12% 
respectively (American Academy of Pediatrics, 2014).  One study of youth aged 15 
through 24 initiating hormonal contraception at four clinics in the San Francisco Bay 
Area found that continuation rates at 12 months were low for all methods of 
contraception and younger age was especially associated with discontinuation (Trussell et 
al., 2013). Continuation rates for LARC methods were higher (76%) than for oral 
contraceptives (44%) at 24 months (Peipert, 2012).  
 The use of LARCs among adolescents is highly variable, depending on local 
access and counseling. As shown in the CHOICE project in St. Louis, 70% of adolescents 
aged 14 through 20 chose a LARC method when access and financial barriers were 
removed (Mestad et al., 2011). Rapid return to pregnancy (RRP), or pregnancy within 
two years of a previous pregnancy, is also associated with nonuse of a LARC method, as 
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demonstrated by another study of postpartum adolescents in Colorado from 2008 through 
2009. Those participants who received a contraceptive implant immediately after delivery 
were significantly less likely to get pregnant within one year (2.6%) as compared to those 
who did not receive the implant (18.6%). By 12 months, 86.3% of implant users had 
continued with the implant method. Most discontinuation was due to irregular bleeding 
(Tocce et al., 2012). Even when LARC methods are discontinued there is a decrease in 
RRP compared with those using non-LARC methods due to the period of time that the 
LARC was in place (Baldwin & Edelman, 2013). Important interventions to increase 
LARC uptake and decrease RRP include counseling, education and contraception 
planning during pregnancy, and immediate initiation of a LARC method following 
abortion or birth. The contraceptive implant can be an especially appealing option to 
adolescents post-abortion or following delivery due to the fact that it can be placed 
immediately (even if breastfeeding), it may decrease total bleeding time and the provider 
can be certain that the patient is not pregnant at the time of placement (Winner et al., 
2012). Given the evidence that LARCs effectively reduce unintended pregnancy and RRP 
in teens, increased provision by health care providers is imperative. 
 
Barriers to LARC placement in Adolescents 
 Some consistent barriers have been recognized among pediatric providers in their 
use of LARCs. A survey of family medicine residents and faculty found that IUDs were 
recommended at very low rates to nulliparous teens, even when they qualified as 
appropriate candidates. Recommendation rates were higher with parous teens (Diaz et al., 
2011). An analysis of the National Survey of Family Growth found that adolescent and 
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young women who had a history of an STI, were nulligravid, unmarried or were not 
currently cohabitating with a monogamous partner were more likely to receive the depot 
medroxyprogesterone acetate (DMPA) injection as opposed to the IUD (Whitaker et al., 
2010). Although the DMPA is considered a long-acting form of contraception, it is user-
dependent, requiring subsequent injections by a health care provider every three months. 
This may reflect providers’ reluctance to offer the IUD to young, nulliparous women 
whom they believe may be at increased risk for PID by nature of their sexual practices. 
This is despite the fact that the World Health Organization (WHO) 2009 Medical Criteria 
Guidelines state that a patient may keep her IUD in place safely through the treatment of 
PID. 
 
Improved Provision in Adolescents 
 One major obstacle to the use of LARCs amongst teens is lack of familiarity with 
the methods. A cross-sectional study of teens and young women at an urban family 
planning clinic found that none of the participants were currently or had ever used the 
IUD and less than half had even heard of the IUD method. Participants were given 
written educational materials and surveyed afterwards, with many reporting interest in the 
IUD due to its efficacy, the fact that it could be used discretely and that it was long-acting 
with little to no maintenance (Fleming et al., 2010). A survey of 144 girls and women 
aged 14 through 24 years (half of whom were 18 years and under) found that providing a 
brief educational intervention including patients seeing and touching actual IUDs, 
significantly increased the proportion of patients who viewed IUDs favorably. Another 
study comprised of 67 women aged 16 through 21 recorded visits with providers and 
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qualitatively analyzed conversations regarding contraception counseling for contextual 
influences and missed opportunities. Features that defined effective counseling included 
interactive and developmentally targeted sessions, including questions/conversations 
about contraceptive use (past, current and knowledge on side effects and failure), lifestyle 
characteristics (who they live with), knowledge of method use (misinformation, myths, 
rumors) and the role of peer influence in method choice and use, including that of the 
current sexual partner. Non-interactive sessions failed to engage patients, and 
contraceptive choice often was made based on provider preference. One major issue 
noted throughout many of the conversations was provider failure to follow-up clear 
patient lack of knowledge with education. For instance, when one patient stated using 
condoms “most of the time” the provider simply stated, “that’s better than never”, rather 
than exploring the reason and potential consequences of inconsistent use (Minnis et al., 
2014). This small but important study highlights the need to tailor contraceptive 
counseling to the dynamic, inconsistent behaviors of adolescents, with providers 
recognizing the context of patients’ lives and experiences as being paramount to their 
contraceptive choice and continuation rates.  
 Pediatricians and family practice providers’ long-term relationships with 
adolescents and families invites discussions related to sexual practices, healthy sexual 
decision-making, and contraceptives counseling. According to the Public Health Service 
Act: Title X Family Planning Program, adolescents are afforded the right to 
confidentiality regarding their sexual health decisions, and should be counseled with this 
in mind. However, the law requires providers to encourage adolescents to include 
guardians in their decision-making (Napili, 2014). The fact that many adolescents will 
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choose to remain independent regarding sexual health decisions highlights the need for 




 Dependable contraception is also incredibly beneficial to women in the 
postpartum period. It is highly recommended that women space their pregnancies at least 
24 months apart to reduce neonatal, infant and maternal morbidity and mortality, (Sober 
& Schreiber, 2014). With this in mind, contraception counseling optimally is initiated as 
part of prenatal care, revisited before hospital discharge and implemented by three weeks 
postpartum, (Sober & Schreiber, 2014). As this is not always a consistent practice 
amongst providers, many women become pregnant within their first few months 
postpartum (Sober & Schreiber, 2014). 
 Ideally, any woman desiring immediate postpartum placement of an IUD or 
implant could have one placed post-placental if there are no contraindications. True 
contraindications include peripartum chorioamnionitis, endometritis or puerperal sepsis. 
Post-placental placement of an IUD is defined as “within 10 minutes of placental 
separation” (ACOG, 2011). This benefits patients who don’t have other contraceptive 
options, are unwilling or unable to return for later insertion or will have a barrier to 
obtaining one at their postpartum visit (Sober & Schreiber, 2014). According to the U.S. 
Medical Eligibility Criteria for Contraceptive Use (2013), immediate postpartum copper 
IUD insertion is classified as Category 1 and immediate postpartum levonorgestrel 
intrauterine system insertion in both breastfeeding and non-breastfeeding women as 
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Category 2. Immediate postpartum placement is an uncommon practice amongst most 
practitioners, probably due to the fact that expulsion rates are higher than for interval 
insertion and may be as high as 24% (ACOG, 2011). Expulsion rates may be lower for 
cesarean section versus vaginal delivery (ACOG, 2011), but expulsion rates overall are 
higher if an IUD is inserted within two to 72 hours post-placental, as opposed to within 
the first ten minutes (Sober & Schreiber, 2014).  
 
Post-abortion LARCs 
 Women who have one or more abortions are also prime candidates for LARC use 
due to their high risk for repeat unintended pregnancy and rapid resumption of ovulation 
(ACOG, 2011). Pre-abortion contraception counseling is imperative, as well as access to 
contraception at the time of abortion. Many providers believe that women are too 
distressed to discuss contraception, however, studies have shown that women appreciate 
the opportunity to explore their options (Cameron et al., 2014). LARCs are the best 
option for women post-abortion due to the fact that they can be inserted immediately and 
are the most reliable method for pregnancy prevention. According to the CDC, implants 
and IUDs can be inserted in almost any patient immediately post-abortion (medical and 
surgical), with IUDs contraindicated in the case of septic abortion or incomplete medical 
abortion (2013). A randomized controlled trial in Sweden of over 100 women who were 
randomized to either immediate or delayed insertion of an IUD showed that those who 
delayed were less likely to attend for insertion, and that uptake was higher for 
appointments made within one week as opposed to two (Cameron et al., 2014).  An 
observational study of contraceptive choice post-abortion in the UK showed that women 
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choosing implant insertion at the time of medical or surgical abortion were 16 times less 
likely to have another abortion within the next two years, as compared to those choosing 
SARCs (Cameron et al. 2010). A retrospective chart review of 4,698 women at a New 
Zealand public hospital abortion clinic over two years investigated subsequent 
pregnancies at 12, 24, 36 and 48 months comparing different birth control methods, in 
particular levonorgestrel implants versus short acting methods. Twenty percent of the 
cohort received an implant, 26% an intrauterine method and 54% chose a short acting 
reversible contraceptive (SARC) method. At 24 months implant users had a 3.8% rate of 
subsequent abortion, whereas SARC users had an 11.6% rate, at 48 months there were 
6.6% and 18.3% rates respectively, showing a significant reduction in unintended 
pregnancies amongst the LARC users (Rose et al., 2015).  
 
Cost Comparison 
 Despite the fact that national public expenditure and investment on family 
planning services exceeds $2 billion and collectively, states report spending $68 million 
of their own funds on abortion services in 2010, the annual direct cost of UPs is estimated 
at $4.5 billion yearly. Additionally, the total cost burden of UP to US taxpayers is 
reported to range from $9.6 to $12.6 billion per year, (Trussel et al., 2015). These 
statistics provide additional support for LARC counseling and implementation, but a 
common reason cited for non-use of LARCs is cost of the actual device as well as the 
high cost of implementation by a provider.  
 One study analyzed the direct medical costs, from the perspective of a public 
payer, of LARC vs. SARC methods against the cost of UPs. The analysis assumed a 
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cohort of 1000 women aged 20 through 29 years, based on the idea that if this group 
switched from a SARC method to a LARC method, it would have the greatest overall 
impact on rates of UP. The analysis used a five-year time span to reflect this group’s 
“time requiring contraception” and outcomes were measured in terms of method failure 
and cost. Method failure was estimated as total number of UPs and costs were reflected 
per drug/method acquisition, administration and method failure, (Trussell et al., 2015). 
The study found that the wholesale cost breakdown per year (including device and 
provider counseling/insertion fees) placed IUDs and implants at approximately $900, ring 
and patch at $1000, Generic OC $400 (13 packs per year), injection $350 and condoms 
around $50 (based on 83 units/yr.) (Trussell et al., 2015). Using three different population 
scenarios that compared cost over time, the higher LARC upfront costs quickly became 
the most cost-effective methods as their duration of use increased. On average, “LARC 
methods became cost-neutral in comparison to SARC methods within three years of use, 
after which point the continued use of LARC methods is cost-saving” (p. 53), and at the 
2.1-year mark LARC methods were still more cost-effective than SARC methods 
(Trussell et al., 2015, p. 53). Cost-savings are especially marked when compared to the 
ring or patch methods, with LARCs achieving cost-neutrality within 0.3-0.4 years, 
respectively. This analysis also took into consideration discontinuation costs of LARC 
methods, due to the fact that a provider visit is required, and found that even this 
inclusion of cost did not change the overall finances saved with LARC vs. SARC 
methods (Trussell et al., 2015).  
 When comparing the cost of LARC vs. pregnancy, live birth and ectopic 
pregnancy intervention costs were estimated at $5,000, with induced abortion at $700 
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(Trussell et al., 2015). These costs are significant, but become much more so when 
considering statistics concerning RRP. Unfortunately, contraceptive access can be limited 
by lack of patient awareness, provider counseling, insurance type, and restrictive 
legislative measures (ACOG, 2015). State and employee restrictive measures based on 
religious beliefs and other reasons for exclusion, including restricting minors’ ability to 
consent to contraceptive services can create roadblocks to those desiring contraception. 
Additionally, lack or type of insurance coverage can serve as a barrier to access. Most 
private health plans cover prescription contraception, but cost sharing and types of 
method covered vary (Trussell, 2015). As stated in the 2015 ACOG Committee Opinion 
paper, “Under the Affordable Care Act (ACA), all FDA-approved contraceptive methods, 
sterilization procedures, and patient contraceptive education and counseling are covered 
for women without cost sharing by all new and revised health plans and issuers as of the 
first full plan year beginning on or after August 1, 2012” (p. 252). This is also the case 
for those insured by Medicaid. Major issues that persist in coverage are exempted 
employers who can choose to not cover contraception as a part of their plan, and 
insurance plans that limit the number of contraceptive products dispensed.  “Insurance 
plan restrictions prevent 73% of women from receiving more than a single month’s 
supply of contraception at a time, yet most women are unable to obtain contraceptive 
refills on a timely basis” (ACOG, 2015). An additional barrier created by some insurers 
and clinic systems is a “requirement” that women “fail” certain contraceptive methods 
before a more expensive method, like a LARC, will be covered (ACOG, 2015). 
 The upfront cost of LARC methods are a barrier to use for some women, but with 
improved public family planning assistance services (Trussell et al., 2015), no-cost 
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sharing insurance coverage, appropriate provider reimbursement for services and longer 
duration of use, they are very economical. As the CHOICE project demonstrated, once 
the cost barrier is removed and quality education is provided about the effectiveness of 
LARC methods, more women of all ages choose LARCs (Peipert et al. 2012). This 
should be weighed against the serious public health costs and societal economic burden 
of UP that could be alleviated by stronger efforts to increase provision of LARCs.  
 
Summary 
 A wide sweeping literature review reveals common themes related to the under-
utilization and uptake of LARC methods in the United States. As shown by multiple 
survey results, providers’ current practice, frequently rooted in outdated knowledge, 
inadequate training, lack of awareness of updated guidelines or reticence to place LARCs 
in certain populations of women, is at the heart of this issue. 
 All of the cited research unanimously agrees that increased uptake of LARCs 
could positively benefit multiple groups of women. When given the opportunity to make 
an informed decision, especially when the financial barrier is removed, most women 
choose either implants or IUDs (McNicholas et al., 2014). Use of LARCs is associated 
with healthier pregnancy spacing (>2 years between pregnancy), decline in repeat 
abortions, and decreased teen pregnancy rates. These three statistics give context to the 







Implications for Current Study 
 An important piece of knowledge that is absent from the literature is the effect 
that being in a rural area can have on providers’ practice, which is why a study of 
Vermont providers is both timely and imperative. Rural Vermont providers may desire to 
provide counseling and implementation of LARC methods, but may face unique 
challenges. The challenges that Vermont healthcare providers face is currently unknown, 
but may include clinical systems that don’t support training in LARC methods, or are 
unable to afford keeping LARC supplies on hand for the potentially few interested 
patients. Other difficulties may include a limited referral system, loss of skills due to few 
patients requesting or desiring LARC methods, and lack of connection to other providers 
or institutions that offer frequent guideline updates through grand rounds or conferences 
(Lunde et al., 2014). Another potential challenge in a rural state like Vermont is the 
distance that a patient would have to travel to reach a clinician who inserts LARCs. This 
inconvenience could act as a serious deterrent to many patients, with the unintended 










Chapter III: Methods and Materials 
Population sample 
 Multiple health care provider types- physicians, NPs and physician assistants 
(PAs), were electronically surveyed through Lime Survey to capture the majority of 
clinicians who provide contraceptive services in the state of Vermont. An introduction to 
the survey and a survey link, were emailed through list serves by direct contacts within 
Vermont chapters of various professional organizations. These include the American 
Academy of Family Physicians, American Academy of Pediatrics, Vermont Nurse 
Practitioner Association, American Congress of Obstetrics and Gynecologists, and 
Physician Assistant Academy of Vermont for a total of approximately 1,100 surveys 
disseminated. Some responses were excluded from the study based on self-reported non-
contraceptive provider, no longer in practice, or not providing clinical services. There 
were seven responses from practitioners outside of Vermont, which were retained in the 
final data analysis. 
 
Identification of Need 
 This research is being conducted in collaboration with the Vermont Child Health 
Improvement Program (VCHIP), a population-based maternal and child health services 
research and quality improvement program of the University of Vermont. VCHIP is 
grant-funded by the March of Dimes for this research. This study analyzed a small 
portion of a comprehensive survey study that VCHIP is utilizing for its research, 
specifically the demographics and knowledge assessment sections. The parent survey 
investigated Vermont providers’ knowledge, current practice, barriers to LARC use, and 
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educational needs assessment. VCHIP will create webinars and LARC implementation 
trainings for providers based on identification of need. VCHIP, the Vermont Department 
of Health, Department of Vermont Health Access, Planned Parenthood of Northern New 
England, University of Vermont Medical Center and this author are all stakeholders in 
this study to assess Vermont providers’ awareness and current practices around the 
counseling and implementation of LARCs.  This study is considered necessary due to 
long-standing and unchanging statistics regarding unintended pregnancies in Vermont 
and their associated negative outcomes. This type of study has not been conducted in 
Vermont and has the potential to shed light on the unique challenges faced by providers 
in a primarily rural state.  
 
Project Development 
 All stakeholders met initially in early March 2015 to discuss the scope and goals 
of this research study, including timeline, groups of providers to be surveyed, categories 
of survey questions, and types of trainings that were made available to interested 
providers. Subsequently, this author, the VCHIP project manager, an adolescent pediatric 
MD from UVM Medical School/Medical Center and a Vermont Department of Health 
representative met multiple times to create the survey that was sent electronically to 
providers of women of reproductive age across Vermont. The survey was sent out to the 






Human Subjects Protection 
 Due to the fact that this author is only participating in the survey portion of this 
research project and only receiving de-identified information from VCHIP survey 
responses, VCHIP and this author submitted two separate Institutional Review Board 
(IRB) proposals. Both IRB proposals were submitted by May 15, 2015, with this author 
submitting a proposal that was deemed exempt by the University of Vermont Institutional 
Review Board. The International Review Board Committee on Human Research in the 
Behavioral and Social Sciences at the University of Vermont was consulted and approved 
of this research. 
 No surveys were distributed, and no information was collected until permission was 
granted by the IRB. Additionally, only providers were surveyed and no patient personal 
health information was collected. 
 
Survey Implementation 
 The complete survey was comprised of a demographics section and a Likert Scale 
questionnaire assessing categories of knowledge, attitudes, current practice, barriers and 
education needs/interests regarding LARCs. It included a hard stop for those who are not 
currently providing clinical services. Study participation was voluntary, and respondents 
elected to be anonymous or not depending on their desire to participate in future 
trainings. Informed consent was implied when respondents read the e-mail description 
and completed the survey. The survey was electronically disseminated in early June with 
three email reminders, and results were collected until August 3, 2015. Participation was 





 The survey instrument used for this study was partially adapted, with permission, 
from the 2008 National Pregnancy & HIV/STI Prevention Survey by author Cynthia 
Harper and California Family Planning Health Care Providers’ Challenges to Same-Day 
Long-Acting Reversible Contraception Provision by author M. Antonia Biggs (2015) at 
the University of California San Francisco Bixby Center for Global Reproductive Health. 
 This needs assessment survey was formatted in an electronic survey tool and 
securely sent via Lime Survey from VCHIP to contacts within professional associations 
mentioned above and then through listservs directly to providers. Survey results were 
returned directly to VCHIP from providers.  
 The first section of the survey inquired about provider participants demographics, 
including: gender, years in practice (post training/education), professional licensure 
qualifications, specialty, main clinical practice setting, age range of patients, geographic 
setting of practice (i.e.: rural, city), zip code, and if they provide direct patient care.  
Table 1.1: Survey: Knowledge Assessment: 
1. 
Have you received any training to provide IUD counseling? q Yes q No 
 If yes, check any that apply  
How long ago was 
this training? 




q 16-20 years q >20 years  
How would you describe this training? q Introductory q Intermediate q In-depth 
Where did you 
receive this training? 
q In school q In residency/ 
fellowship/ 
clinical training 








Have you received any training to provide IUD insertion? q Yes q No 
If yes, check any that apply  
How long ago was 
this training? 




q 16-20 years q >20 years  
How would you describe this training? q Introductory q Intermediate q In-depth 
Where did you 
receive this training? 
q In school q In residency/ 
fellowship/ 
clinical training 
q In practice q Other (CME, 
conference) 
3. 
Have you received any training to provide Implant 
counseling? 
q Yes q No 
If yes, check any that apply  
How long ago was 
this training? 




q 16-20 years q >20 years  
How would you describe this training? q Introductory q Intermediate q In-depth 
Where did you 
receive this training? 
q In school q In residency/ 
fellowship/ 
clinical training 
q In practice q Other (CME, 
conference) 
4. 
Have you received any training to provide Implant insertion? q Yes q No 
If yes, check any that apply 
How long ago was 
this training? 




q 16-20 years q >20 years  
How would you describe this training? q Introductory q Intermediate q In-depth 
Where did you 
receive this training? 
q In school q In residency/ 
fellowship/ 
clinical training 
q In practice q Other (CME, 
conference) 
 
5. How would you rate your knowledge of the Copper T IUD 
 High Moderate Low None 
Contraceptive efficacy q q q q 
Side effects q q q q 
Insertion/removal procedure q q q q 
  
6. How would you rate your knowledge of the Levonorgestrel-releasing IUD  
 High Moderate Low None 
Contraceptive efficacy q q q q 
Side effects q q q q 
Insertion/removal procedure q q q q 
 
7. How would you rate your knowledge of the Implant  
 High Moderate Low None 
Contraceptive efficacy q q q q 
Side effects q q q q 




8. How comfortable do you feel counseling a woman about  
 Very 
Comfortable 
Comfortable Uncomfortable Very 
Uncomfortable 
Copper T IUD  q q q q 
Levonogestrel-releasing IUD  q q q q 
Implant  q q q q 
 
9. Would you recommend and IUD/implant for women with the following? 
 Copper T IUD 
(Paragard®)  
Levonogestrel-releasing 




Yes No Unsure Yes No Unsure Yes No Unsure 
Menorrhagia q q q q q q q q q 
Dysmenorrhea q q q q q q q q q 
Fibroids q q q q q q q q q 
Diabetes q q q q q q q q q 
Obesity q q q q q q q q q 
Smoker q q q q q q q q q 
History of HTN q q q q q q q q q 
Iron-deficiency 
anemia 
q q q q q q q q q 
 
Literature Review 
 A comprehensive review of the literature was conducted to reveal study results 
and common themes regarding healthcare provider knowledge and practice around 
LARCs. Studies investigating populations of women affected by LARCS were also 
included to give appropriate historical and current context to this research. Several search 
engines were used, including: CINAHL, OVID Medline, Web of Science and PubMed. 
Search terms included individual and combination key words, including: long acting 
reversible contraception, contraception, provider knowledge, post-partum contraception, 
post-abortion contraception, adolescents, LARCs, IUDs, contraceptive implant, provider 
practice. The majority of the research included in the literature review was from the last 




 Completed surveys were returned to VCHIP via Lime Survey, and data for 
separate sections was compiled with the above demographic and knowledge dataset given 
to this author de-identified. Responses were extracted from an Excel spreadsheet, 




















Chapter IV: Results and Discussion 
 
 
 A total of 126 complete surveys out of approximately 1000 were returned from 
various healthcare specialty providers, four of which are not currently in clinical practice 
and therefore were asked to not answer all survey questions. Their responses are limited 
to the demographics section. Respondents included: 83 attending physicians, seven 
fellow/residents, 22 nurse practitioners, 11 physician assistants, two medical students and 
one without a response. Included in this group were 31 ob/gyn or women’s health 
specialists, 43 family medicine, 36 pediatric, nine internal medicine/adult, five from other 
specialties and two who did not specify. There was a broad range of years in practice 
(post-training), including 35 providers with 0-5 years, 17 provider with 6-10 years, 12 
providers with 11-15 years, 17 providers with 16-20 years and 44 providers with 21 or 




0-­‐5	   6-­‐10	   11-­‐15	   16-­‐20	   21	  or	  more	  





 Greater than half of the providers practice at a University Medical center (33%) 
and private clinics (31%), with the remainder at community hospitals, family planning 
clinics, rural health clinics, federally qualified health centers and rural health centers. 
Seven practitioners were from out of state (five in NH, one in MA and one in ME), with a 
total of 117 Vermont-specific practitioners. Most of these practitioners practice in 
Chittenden County (67), while others practice in Addison and Orange Counties (4), 
Franklin County (5), Lamoille and Bennington Counties (6), Orleans and Caledonia 
Counties (2), Washington County (11), Windsor County (7) and 1 in Grand Isle, Rutland 
and Windham Counties.  
 
Table 1.2: Main Clinical Practice Settings 
  Frequency Percent Valid Percent 
Cumulative 
Percent 
 Community hospital/clinic 22 17.6 17.6 17.6 
University medical center/clinic 41 32.8 32.8 50.4 
Private office or clinic 39 31.2 31.2 81.6 
Family planning clinic 6 4.8 4.8 86.4 
Federally Qualified Health Center 
(FQHC) 10 8.0 8.0 94.4 
Rural Health Center (RHC) 3 2.4 2.4 96.8 
University/College health center 1 .8 .8 97.6 
Other 3 2.4 2.4 100.0 
Total 125 100.0 100.0   
 
Figure 1.3: Type of Providers 
Nurse	  Practitioners	  Physicians	  
Physician	  Assistants	  fellow/resident	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 The knowledge assessment portion of the survey included questions about 
training in the counseling and insertion of LARCs. Seventy six percent of respondents 
received training in IUD counseling, most of which occurred in the last five years and 
was considered by the practitioner to be intermediate or in-depth. These trainings 
primarily occurred in residency, fellowship or clinical training. Fifty three percent of 
providers reported in-depth training on IUD insertion that occurred during residency, 
fellowship, clinical training, or in practice. IUD insertion training was anywhere from 
five years to over 20 years ago.  
 Sixty percent of practitioners reported training to provide implant counseling, also 
within the last five years at an intermediate to in-depth level across a broad range of 
settings, including at conferences for CMEs, in residency, fellowship, clinical practice 
and in practice. Of the <40% of providers who have received training in implant 
insertion, most occurred less than five years ago at a conference or in practice and was 
considered to be in-depth.  
 Assessment of providers’ knowledge included ratings of LARC methods in terms 
of efficacy, side effects, and insertion and removal processes. Responses regarding the 
copper IUD included: 88% reporting moderate or high knowledge of the efficacy of the 
method, 81% moderate to high knowledge of side effects and 58% moderate to high 
knowledge of the insertion and removal processes. Responses regarding the 
levonorgestrel IUD included: 94% moderate to high knowledge of the efficacy of the 
method, 88% moderate to high knowledge of side effects, 63% moderate to high 
knowledge of the insertion and removal processes. Responses regarding the implant, 85% 
reported moderate to high knowledge of the efficacy, 78% moderate to high knowledge 
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of side effects and 59% moderate to high knowledge of the insertion and removal 
process. The majority of providers stated that they were comfortable or very comfortable 
counseling on each method, including 83% for the copper IUD, 88% for the 
levonorgestrel IUD and 84% for the implant.  
 Providers were also asked about their recommendation of different LARC 
methods for women with various medical conditions. The majority of respondents (60% 
to 89%) were confident in recommending both IUDs (copper and levonorgestrel) and 
implants to women with diabetes, obesity, smokers, history of hypertension, and women 
breastfeeding immediately postpartum. Most (40% to 75%) were not comfortable 
recommending the Copper-T IUD to women with menorrhagia, dysmenorrhea, iron-
deficiency anemia or fibroids.  
 A separate statistical analysis was run to compare results from “urban” Vermont 
providers against providers from the rest of the state, which was considered “rural”. 
“Urban” was classified as those providers who recorded zip codes within Chittenden 
County, which has the highest population in the state, sources of public transportation, as 
well as access to a Level I Trauma Medical Center. “Rural” was classified as zip codes 
that were outside of Chittenden County. The greatest differences between rural and urban 
providers were evident in the section rating knowledge of LARC eligibility for women 
with various medical conditions. In general, there were a greater number of providers 
who reported “uncertainty” for women with various conditions. Specifically, 30% of 
rural providers stated uncertainty of whether they would recommend the Copper T IUD 
for women with menorrhagia, versus 15% of urban providers. Similarly, 53% and 17% of 
rural providers reported uncertainty with the recommendation of the Copper T IUD for 
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women with fibroids and smokers, respectively, versus 39% and 6% of urban providers. 
When asked about the Levonorgestrel-releasing (hormonal) IUD, 10% of rural providers 
reported uncertainty for women with menorrhagia, versus 6% of urban providers. Again, 
53% and 21% of rural providers were uncertain about the hormonal IUD for women with 
fibroids and smokers, respectively, versus 29% and 4% of the urban providers. Twice as 
many (15%) rural providers were uncertain about the hormonal IUD for women with 
iron-deficiency anemia, versus urban providers (7%). The only implant statistic that was 
significantly different was uncertainty about the implant for women who smoke, with 
rural providers reporting 32% and urban providers reporting 20%.  
 The majority of providers reported patient eligibility that is in line with the CDC 
MEC, however, there was consistently 10%-45% uncertainty about the indications of 
LARC methods. The following medical conditions are category 2 with use of the Copper 
T IUD: iron deficiency anemia, dysmenorrhea, and fibroids. Diabetes mellitus and 
fibroids are category 2 with the Levonorgestrel-releasing IUD and diabetes mellitus is 
category 2 with the implant. All other medical issues are category 1 with all of the 
methods, meaning that there are no restrictions to their usage. This highlights the fact that 
many providers, especially in rural areas of Vermont, may not be informed about current 
evidence-based guidelines for LARCs and therefore may be excluding eligible patients 
from counseling and insertion/referral. 
 As previously noted, there is a high level of uncertainty throughout all categories 
of knowledge concerning medical eligibility. Additionally, only 50% reported a high 
level of knowledge about the IUDs and implant side effects, and contraceptive efficacy, 
with moderate knowledge concerning IUD and implant insertion/removal processes. 
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However, the majority (70%-80%) of respondents stated that they felt comfortable or 
very comfortable counseling on all types of LARCs..  
 Despite subjective uncertainty, all rural and urban providers reported a moderate 
to high level of knowledge about the side effects, contraceptive efficacy and 
insertion/removal. At least 40% of all providers, urban and rural, also reported being very 
comfortable counseling women about all three methods of LARC. 









CDC Medical Eligibility Criteria for Contraceptive Use (2012) 
Category I= no restriction, method can be used 
Category II= advantages generally outweigh theoretical or proven risks 
*Not evaluated by CDC MEC 

















Copper T IUD Yes Uncertain No CDC MEC 
Category I/II 
 % n % n % n  
Menorrhagia 5 6 21 26 74 93 Yes (II) 
Dysmenorrhea 9 11 32 40 59 74 * 
Fibroids 16 20 45 57 39 49 Yes (II) 
Diabetes 70 88 26 33 4 5 Yes (I) 
Obesity 80 101 18 23 2 3 Yes (I) 
Smoker 88 111 10 13 2 3 Yes (I) 
History of Hypertension 86 108 12 15 2 3 Yes (I) 
Fe-deficiency anemia 33 42 27 34 41 52 Yes (II) 
Breastfeeding 
immediately postpartum 
73 92 18 23 9 11 Yes (I) 
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CDC Medical Eligibility Criteria for Contraceptive Use (2012) 
Category I= no restriction, method can be used 
Category II= advantages generally outweigh theoretical or proven risks 
*Not evaluated by CDC MEC 






























Yes Uncertain No CDC MEC 
Category I/II 
 % n % n % n  
Menorrhagia 88 111 8 10 4 5 Yes (I) 
Dysmenorrhea 83 104 11 14 6 8 * 
Fibroids 50 63 39 49 11 14 Yes (II) 
Diabetes 71 89 23 29 3 4 Yes (I) 
Obesity 80 101 16 20 4 5 Yes (I) 
Smoker 75 95 11 14 14 18 Yes (I) 
History of Hypertension 74 93 20 25 6 8 Yes (I) 
Fe-deficiency anemia 89 112 10 13 1 1 Yes (I) 
Breastfeeding 
immediately postpartum 
62 78 20 25 18 23 Yes (II) 
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Table 1.5: Provider Recommendation of Implant Based on Medical Eligibility 
 
                   
 
N= 126 
                 CDC Medical Eligibility Criteria for Contraceptive Use (2012) 
                Category I= no restriction, method can be used 
                Category II= advantages generally outweigh theoretical or proven risks 
               *Not evaluated by CDC MEC 
 










Chapter 5: Discussion 
This study revealed that the majority of respondents rated themselves as highly 
knowledgeable about LARCs. Most healthcare providers were trained in LARC insertion 
and/or counseling; IUDs slightly more so than implants. Most of the healthcare providers 
were trained within the last five years, with some receiving training in IUD insertion as 
long as twenty years ago. Training for IUD counseling and insertion occurred primarily 
in residency, during fellowship or clinical training, or in practice. Training for implant 
insertion occurred most often in conferences or in practice. 
 This study revealed that Vermont providers report slightly less training in LARC 
insertion as compared with other national survey-based studies. About half (53%) of the 
Vermont providers reported IUD insertion training, and less than 40% reported implant 
insertion training. The 2013 study of ObGyn residents by Tang et al. reported 92% 
training for IUDs and 51% for implants, whereas the Harper et al., 2013 NP study cited 
66% of women’s health NPs and only 12% of primary care NPs inserted IUDs. These 
studies were both conducted on a national scale.  
 A significant feature revealed by this study is the relatively high percentage of 
providers who report uncertainty about LARC medical eligibility criteria. This is even 
more apparent when stratified for urban and rural providers. This uncertainty could be 
attributed to two different factors. The first factor could be a lack of knowledge about 
whether a particular method is appropriate for a particular medical condition. The second 
factor could be that reported uncertainty may reveal provider discernment around 
recommendations based on unique patient situations. In other words, it is not a true lack 
of knowledge of guidelines but rather a reflection of the often “gray area” of medical 
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decision-making. Additionally, the CDC categorizations leave room for interpretation 
about which patients are most eligible. Therefore, it is difficult to determine whether 
providers are perfectly knowledgeable about the medical eligibility criteria or not.  
  Many other studies have highlighted lack of evidence-based knowledge as a 
reason for low LARC uptake. For instance, nurse practitioners in the 2013 study reported 
low candidacy for women with a history of ectopic pregnancy, STI in the last 2 years and 
PID history- all of which do not exclude them from LARC use according to the CDC 
MEC (Harper et al. 2013). ObGyn residents who were a part of a 2010 survey study were 
also deficient in certain areas of knowledge, including not knowing the non-contraceptive 
profiles of LARCs and not being familiar with all of the medical eligibility criteria (Tang 
et al., 2013). Although these particular health concerns were not measured in this study, it 
highlights a ubiquitous gap in provider knowledge.  
 
Limitations and Enhancements to Research  
 The primary enhancement of this research was collaboration with VCHIP, a well-
established organization that is affiliated with the University of Vermont along with other 
well-respected partners. A secondary enhancement was access to a large cohort of 
reproductive healthcare practitioners throughout the state of Vermont.  
 Limitations of this study include reporting bias due to the subjective nature of the 
survey methodology. Respondents may have unintentionally inflated their responses 
regarding knowledge, as well as the intensity of the training that they have received. The 
survey may have only been completed by providers who feel competent in their 
knowledge and use of LARCs, contributing to response bias. Further, purposive versus 
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random sampling was used given the constraints of the study.   A  significant limitation  
in this study is that the definitive number of surveys distributed is unknown. This is due 
to the fact that surveys were administered through third party volunteers within 
professional organizations at their convenience and discretion. It is estimated that there 
were over 1000 surveys emailed, with 126 returned, resulting in a 12% response rate 
based on 1000 distributed surveys.  Additionally, this author only received partial data 
derived from the survey.  The latter two limitations may result in an inaccurate reflection 
of the true knowledge and practice patterns of Vermont practitioners. Finally, results may 
not be generalizable to other practices and states due to differing provider demographics 
including ethnicity, practice environment, healthcare and insurance systems. 
 
Implications 
  Increased provision of LARCs in Vermont has the potential to benefit society as 
well as individuals within diverse social groups. Several areas of research could inform 
and improve LARC practice patterns. First, a study investigating specific challenges of 
providers in rural Vermont, giving context to the level of uncertainty that was 
demonstrated in their responses. A second area of research would be a review of 
reimbursement for LARC methods based on practice type, along with an exploration of 
systems barriers to LARC use. For example, do most practices require a two-part visit for 
LARC placement? A third study could provide standardized trainings to providers in 
multiple practice settings and measure and compare changes in LARC uptake over time. 
 These studies could provide context for some of the unclear results of this study 
and deliver much needed clarity around Vermont provider knowledge gaps.  With these 
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necessary pieces in place, actionable steps could be furthered towards the larger goal of 
reducing unintended pregnancies. 
 
Conclusion 
 This study reveals a gap between what providers’ believe they know and current 
evidence-based guidelines. The results of this study elucidate the importance of improved 
and ongoing LARC trainings for providers, to ensure that patients have complete 
information to make informed decisions regarding their care. Toward the end of 
increasing LARC use and decreasing unintended pregnancies, we now have an increased 
understanding of Vermont providers’ LARC knowledge and knowledge gaps. This 
improved understanding may contribute to the development of interventions for providers 
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